MarketPulse

Phase II clinical trial

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Prf Technologies Ltd.

PRF Technologies Advances OcuRing™-K Toward Phase II Trial With FDA IND Clearance

PRF Technologies gains FDA clearance for OcuRing™-K, a bio-erodible intraocular ring delivering ketorolac post-surgery, with Phase II trials beginning mid-2026.
PRFXcataract surgeryPhase II clinical trial
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Levicept's Osteoarthritis Drug Shows NSAID-Comparable Results Ahead of Major Medical Conference

Levicept will present Phase II data for LEVI-04 at OARSI 2026, showing pain relief comparable to NSAIDs in 518-patient trial published in The Lancet.
PFEdisease modificationpain management
GlobeNewswire Inc.GlobeNewswire Inc.··Biomea Fusion, Inc.

Biomea Fusion's Diabetes Drug Shows Durable Benefits Nine Months Post-Dose

Biomea Fusion presents positive Phase II data for icovamenib in type 2 diabetes, showing durable 1.2% HbA1c reduction nine months after dosing with favorable safety profile.
BMEAobesityType 2 diabetes